Skip to main content
Clinical Trials/NCT04134377
NCT04134377CompletedNot Applicable

High-Protein Food Snack and Albumin Outcomes in Hemodialysis Patients

University of Florida2 sites in 1 country52 target enrollmentStarted: October 1, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
52
Locations
2
Primary Endpoint
Serum albumin

Study Overview

Brief Summary

The study team aims to provide a food snack that is high in protein (30 g) for two weeks each month (6 treatments per patient per month) for 6 consecutive months, post-dialysis treatment, to in-center hemodialysis patients of all vintages and with all levels and types of comorbidities. The study team will compare changes in serum albumin during the intervention (6 months) using the patients' own serum albumin results that are collected for three months prior to and three months after the intervention. Additionally, the study team will determine participants' dietary habits and appetite pre-, during and post-intervention.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 74 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Chronic Hemodialysis (CHD) therapy
  • Active and permanent patients to the area Fresenius Kidney Care (FKC) Dialysis clinic
  • No food allergies or dietary restrictions
  • No contraindications to consuming anything by mouth as per the medical director and/or personal reporting.

Exclusion Criteria

  • Patients unable to commit to the full time commitments of the study
  • Those who have food allergies, especially to Chicken, Pork Sausage, Eggs, Fresh Cilantro, Red and yellow bell peppers, Cucumbers, Mrs. Dash Grill Seasoning, Newman's Own Ranch Salad Dressing, Minced garlic, Sweet pickle relish, Vidalia onions, tomatoes
  • Dietary restrictions as medically indicated,
  • Trouble chewing/swallowing as confirmed by medical director, and/or personal reporting.

Outcomes

Primary Outcomes

Serum albumin

Time Frame: Up to 12 months

Change in grams of albumin per deciliter of blood (g/dL). Pre-, during, and 3-months post-intervention will complete monthly serum albumin lab draws.

Secondary Outcomes

  • Serum phosphorus(Up to 12 months)
  • Diet Intake(Up to 12 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials